Pepsinogen Bibliography

  1. Emerging blood-based biomarkers for detection of gastric cancer - Zane Kalniņa et al, World J Gastroenterol 2015 November 7; 21(41): 11636-11653
  2. Serum Gastrin and the Pepsinogen I/II Ratio as Markers for Diagnosis of Pre-malignant Gastric Lesions - Afshin Shafaghi et al,  Asian Pacific J Cancer Prev, 14 (6), 3931-3936
  3. Changing Trends of Serum Pepsinogen I/II Ratio in Asymptomatic Subjects - Jae Hoon Yang et al, Korean J Helicobacter Up Gastrointest Res 2012; 12:96-102)
  4. Serum Pepsinogen test for early detection of gastric cancer in a European Country - Lomba-Viana et al, European Journal Gastroenterology & Hepatology, Jan 2012; Vol 24, Issue 1- p 37-41
  5. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titre - Takeichi Yoshida et al, Int. J. Cancer: 134, 1445-1457 (2014)
  6. Significance of Serum Pepsinogens as a Biomarker of Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis - Ya-kai Huang et al, PLOS ONE, DOI: 10.1371/journal.pone 0142080, November 10, 2015
  7. Pepsinogen testing for evaluation of the success of Helicobacter Pylori eradication at 4 weeks after completion of therapy - Marcis Leja et al, MEDICINA 50 (2014) 8-13
  8. Serum pepsinogen II is a better diagnostic marker in gastric cancer - Xue-Yaun Cao et al, World J Gastroenterology 2012, December 28; 18(48): 7357 – 7361
  9. Screening of Gastric Cancer: Who, When and How - Jaw-Town Lin, Clinical Gatroenterology and Hepatology 2014; 12: 135-138
  10. Diagnosis and Management of High Risk Group for Gastric Cancer - Hyuk Yoon and Nayoung Kim, Gut and Liver, Vol 9, No 1, January 2015, PP 5-17
  11. Gastric Cancer Detection Using Gastric Juice Pepsinogen and Melanoma-Associated Gene RNA - Hyun-Dong Chae, MD et al, AM J Clin Pathol 2013; 140: 209-214
  12. Accuracy and Cut-Off Values of Pepsinogens I, II and Gastrin 17 for Diagnosis of Gastric Fundic Atrophy: Influence of Gastritis - Dariush Nasrollahzadeh et al, PLoS ONE 6(10): e26957. doi:10.1371/journal.pone.0026957, 2011
  13. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran. - Nejadi-Kelarijani F et al, Asian Pac. J. Cancer, Prev 2014; 15(17): 7433-6
  14. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers - Agréus L et al, Scand J Gastroenterol: 2012 Feb;47(2):136-47
  15. Relationships among serum pepsinogen I, serum pepsinogen II and gastric mucosal histology. - Sanloff IM et al. Gastroenterology, 83: 204-209, 1982
  16. The gastric precancerous process. - Correa P. Cancer Survey, 2: 438-450, 1983
  17. Gastric Cancer Screening Using Serum Tests (Stomach Dry Dock) -Study of the Systems of the First Screening for Cancer-susceptible Subjects by Serum Pepsinogen Levels and the Secondary Close-examination by Every-Other-Year Panendoscopy. - Miki K, Nippon Shokaki shudankenshin gakkaishi, 84: 141-144, 1989

You can change the country filter for contents in our website. You will then see local contact information and other information available for that country. Please choose your country in the list below:

Please log in to react

Welcome to Fujirebio

It looks as if you are visiting from the United States. The content of this website is not destined for United States visitors.

If you continue your visit you confirm that you understand that not all of the products you will see listed are FDA cleared. FDA cleared products may not be cleared for all indications mentioned on this site. Product claims may differ from country to country based on regulations and approvals.

Please contact your country representative for further details.